The only safe assumption to make about today’s current gold standard imaging modality used to identify and evaluate atheromatous plaque in the peripheral arteries is that there is not one gold standard. To locate and evaluate these plaques that cause peripheral vascular disease (PVD), physicians have multiple tried-and-true imaging tests at their disposal.
July 10, 2008 - Boston Scientific Corp. this week launched its Atlantis .018 Peripheral Imaging Catheter, which reportedly brings existing 40 MHz coronary standard ultrasound imaging resolution to peripheral interventions. The company said the product is available for immediately release in the U.S.
Safe delivery of the balloon or stent through fragile vasculature during percutaneous transluminal coronary angioplasty (PTCA) procedures is an important criterion for successful patient outcomes.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
InTouch Technologies Inc. offers StrokeRESPOND to extend the functionality of its telemedicine, Remote Presence robotic ...
Thoratec Corp. received FDA approval of its PMA (premarket approval) application, allowing the use of its HeartMate II LVAS (left ventricular assist system) as a bridge-to-transplantation (BTT) in patients suffering from advanced-stage heart failure.
Northeast Monitoring’s DR200/HE is a combination 14-day Holter plus 30-day Event recorder integrated into a single unit ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
July 9, 2008 - Omron Healthcare Inc. released a new portable, single patient use monitor series, the HBP-T105. The new ...
The FDA cleared GE Healthcare’s new LightSpeed CT750 HD, said to be the world’s first high-definition CT scanner that ...
Vascular Insights received 510(k) clearance from the FDA to market its ClariVein infusion catheter for infusion of physician-specified agents in the peripheral vasculature. ClariVein is a percutaneous, 2 2/3 Fr (0.035-inch) catheter, containing a rotating wire driven by a motor, that enhances fluid dispersion in the treatment area.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
July 9, 2008 – An article in the July issue of The Journal of Clinical Hypertension indicates an increased intake in ...
The Abiomed Inc. Impella 2.5 cardiac assist device was FDA cleared in 2008 for use for partial circulatory support for periods up to six hours. The intra-aortic balloon pump (IABP) also has 510(k) clearance and approximately 110,000 are used each year in the U.S.
The FloTrac is reportedly the first minimally invasive hemodynamic monitoring device that connects to any existing arterial line and requires no manual calibration. The latest enhancement to the FloTrac software empowers clinicians with greater flexibility to trend and analyze the patient parameters in order to make better informed decisions, said the company.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
July 9, 2008 – The Medical Imaging & Technology Alliance (MITA) today applauded the U.S. Congress for passing Medicare ...
The ACUSON SC2000 volume imaging ultrasound system acquires nonstitched, real-time full-volume 3D images of the heart in ...
The Sorin Group said the FDA approved to market the CRT model of its OVATIO family, reportedly the smallest CRT defibrillator (CRT-D) available. The OVATIO CRT 6750 is shaped to offer ease of implantation and long-term patient comfort, and is designed to allow more flexibility in the management of cardiac resynchronization and antitachyarrhythmia therapy due to its Brady-Tachy Overlap (BTO).